Central iliac arteriovenous anastomosis for hypertension: targeti.pdf (730.09 kB)
0/0

Central iliac arteriovenous anastomosis for hypertension: targeting mechanical aspects of the circulation.

Download (730.09 kB)
journal contribution
posted on 22.11.2019 by Vikas Kapil, Paul A. Sobotka, Manish Saxena, Anthony Mathur, Charles Knight, Eamon Dolan, Alice V. Stanton, Melvin D. Lobo
Raised blood pressure is the leading attributable risk factor for global morbidity and mortality. Real world data demonstrates that half of treated patients are at elevated cardiovascular risk because of inadequately controlled BP. In addition to pharmacotherapy, certain interventional strategies to reduce blood pressure and cardiovascular risk in hypertension can be considered according to international guidelines. One of the newer technologies entering this field is a proprietary arteriovenous coupler device that forms a fixed flow arteriovenous conduit in the central vasculature. In this review, we examine the development of and rationale for the creation of a central arteriovenous anastomosis in patients with hypertension and review the proposed mechanisms by which it may ameliorate hypertension. We critically review the clinical trial evidence base to date and postulate on future therapeutic directions.

Funding

ROX Medical, St Jude Medical, and Cardiosonic, and grants from Medtronic. ROX Medical funded the ROX CONTROL HTN study. ROX Medical; equity in Cibiem, Ablative Solutions, and Rainbow Medical; and personal fees from Abbott Ventures and Boston Scientific.

History

Comments

The original article is available at link.springer.com

Published Citation

Kapil V, Sobotka PA, Saxena M, Mathur A, Knight C, Dolan E, Stanton A, Lobo MD. Central iliac arteriovenous anastomosis for hypertension: targeting mechanical aspects of the circulation. Current Hypertension Reports. 2015;17(9):585.

Publication Date

01/09/2015

Publisher

Springer

PubMed ID

26228235

Licence

Exports

Logo branding

Licence

Exports